NASDAQ : OTLK
Outlook Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.4935 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 120.14M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Outlook Therapeutics, Inc. (OTLK) reported revenue of -1.16M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | -1.16M | 1.41M | ||||
| Cost of Revenue | 1.11M | 1.36M | 26.45M | 42.33M | 38.96M | |
| Gross Profit | -2.28M | 57.20K | -26.45M | -42.33M | -38.96M | |
| Selling, General & Admin | 36.00M | 39.94M | 29.94M | 26.67M | 20.74M | 12.77M |
| Research & Development | 17.36M | 27.18M | 41.76M | |||
| Operating Expenses | 53.36M | 67.12M | 71.70M | 26.67M | 20.74M | 12.77M |
| Operating Income | -55.64M | -67.06M | -71.70M | -53.13M | -63.07M | -51.73M |
| Interest Expense | -264.16K | -283.13K | -3.16M | -2.53M | -1.49M | -936.13K |
| Interest & Investment Income | 89.75K | 89.74K | 906.15K | 971.48K | ||
| Earnings From Equity Investments | -165.18K | -141.01K | -100.74K | -11.00K | -48.73K | -46.34K |
| Other Non Operating Income (Expenses) | 27.83K | 9.49M | 1.15M | 50.92K | 465.78K | -452.15K |
| EBT Excluding Unusual Items | -55.95M | -57.90M | -72.91M | -54.65M | -64.14M | -53.16M |
| Other Unusual Items | -6.73M | -6.07M | -2.46M | -4.33M | -1.91M | |
| Pretax Income | -62.68M | -63.98M | -75.36M | -58.98M | -66.05M | -53.16M |
| Income Tax Expense | -1.55M | -1.55M | 2.80K | 2.80K | 2.80K | 2.00K |
| Earnings From Continuing Operations | -61.12M | -62.42M | -75.37M | -58.98M | -66.05M | -53.16M |
| Net Income | -61.12M | -62.42M | -75.37M | -58.98M | -66.05M | -53.16M |
| Net Income to Common | -61.12M | -62.42M | -75.37M | -58.98M | -66.05M | -53.16M |
| Shares Outstanding (Basic) | 81.72M | 34.80M | 18.55M | 12.51M | 10.60M | 7.63M |
| Shares Outstanding (Diluted) | 81.72M | 34.80M | 18.55M | 12.51M | 10.60M | 7.63M |
| EPS (Basic) | -0.75 | -1.79 | -4.06 | -4.72 | -6.23 | -6.96 |
| EPS (Diluted) | -0.75 | -1.79 | -4.06 | -4.72 | -6.23 | -6.96 |
| Free Cash Flow | -56.15M | -51.83M | -68.79M | -42.97M | -56.67M | -54.25M |
| Free Cash Flow Per Share | -0.69 | -1.49 | -3.71 | -3.44 | -5.34 | -7.11 |
| Gross Margin | 4.05% | |||||
| Operating Margin | -4,744.25% | |||||
| Profit Margin | -4,416.22% | |||||
| Free Cash Flow Margin | -3,666.65% | |||||
| EBITDA | -55.53M | -66.94M | -71.59M | -53.08M | -62.87M | -51.46M |
| D&A For EBITDA | 104.02K | 117.05K | 113.86K | 44.19K | 204.69K | 262.14K |
| EBIT | -55.64M | -67.06M | -71.70M | -53.13M | -63.07M | -51.73M |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 11.24M | 8.08M | 14.93M | 23.39M | 17.40M | 14.48M |
| Cash & Short-Term Investments | 11.24M | 8.08M | 14.93M | 23.39M | 17.40M | 14.48M |
| Accounts Receivable | 1.64M | 1.49M | ||||
| Receivables | 1.64M | 1.49M | ||||
| Inventory | 5.04M | 3.34M | ||||
| Prepaid Expenses | 5.24M | 4.48M | 12.49M | 7.59M | 10.12M | 7.03M |
| Total Current Assets | 23.17M | 17.39M | 27.42M | 30.98M | 27.52M | 21.51M |
| Property, Plant & Equipment | 185.18K | 225.51K | 274.64K | 26.17K | 70.36K | 275.05K |
| Long-Term Investments | 2.53M | 552.18K | 693.19K | 793.93K | 804.93K | 853.66K |
| Long-Term Deferred Charges | 282.42K | 119.42K | ||||
| Other Long-Term Assets | 304.05K | 135.10K | 439.28K | 501.30K | 12.59K | 174.59K |
| Total Assets | 26.18M | 18.58M | 28.82M | 32.30M | 28.53M | 22.81M |
| Accounts Payable | 6.81M | 10.19M | 7.97M | 6.57M | 3.49M | 2.20M |
| Accrued Expenses | 3.28M | 5.31M | 3.24M | 2.75M | 3.43M | 1.73M |
| Current Portion of Long-Term Debt | 18.23M | 29.95M | 29.44M | 35.55M | 10.92M | 904.20K |
| Current Portion of Leases | 64.02K | 58.90K | 50.91K | 4.27K | 38.75K | 69.32K |
| Current Income Taxes Payable | 302.00K | 302.00K | 1.86M | 1.86M | 1.86M | 1.86M |
| Total Current Liabilities | 28.68M | 45.81M | 42.55M | 46.73M | 19.73M | 6.75M |
| Long-Term Debt | 10.89M | |||||
| Long-Term Leases | 140.13K | 188.80K | 246.92K | 4.27K | 43.01K | |
| Other Long-Term Liabilities | 7.76M | 4.77M | 59.10M | 6.22K | 57.14K | 522.92K |
| Total Liabilities | 36.58M | 50.77M | 101.90M | 46.74M | 19.79M | 18.20M |
| Common Stock | 1.87M | 538.87K | 239.06K | 130.13K | 2.27M | 1.76M |
| Additional Paid-In Capital | 641.28M | 572.98M | 469.97M | 453.35M | 415.40M | 345.73M |
| Retained Earnings | -653.54M | -605.71M | -543.28M | -467.92M | -408.94M | -342.88M |
| Total Common Equity | -10.39M | -32.19M | -73.08M | -14.44M | 8.74M | 4.61M |
| Shareholders' Equity | -10.39M | -32.19M | -73.08M | -14.44M | 8.74M | 4.61M |
| Total Liabilities & Equity | 26.18M | 18.58M | 28.82M | 32.30M | 28.53M | 22.81M |
| Total Debt | 18.43M | 30.19M | 29.74M | 35.56M | 10.96M | 11.90M |
| Net Cash (Debt) | -7.19M | -22.11M | -14.81M | -12.16M | 6.44M | 2.57M |
| Net Cash Per Share | -0.09 | -0.64 | -0.80 | -0.97 | 0.61 | 0.34 |
| Filing Date Shares Outstanding | 243.45M | 64.11M | 24.91M | 13.01M | 11.41M | 11.21M |
| Total Common Shares Outstanding | 187.10M | 53.89M | 23.91M | 13.01M | 11.37M | 8.82M |
| Working Capital | -5.51M | -28.43M | -15.14M | -15.75M | 7.79M | 14.76M |
| Book Value Per Share | -0.06 | -0.60 | -3.06 | -1.11 | 0.77 | 0.52 |
| Tangible Book Value | -10.39M | -32.19M | -73.08M | -14.44M | 8.74M | 4.61M |
| Tangible Book Value Per Share | -0.06 | -0.60 | -3.06 | -1.11 | 0.77 | 0.52 |
| Machinery | 1.07M |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -61.12M | -62.42M | -75.37M | -58.98M | -66.05M | -53.16M |
| Depreciation & Amortization | 104.02K | 117.05K | 113.86K | 44.19K | 204.69K | 262.14K |
| Loss (Gain) on Equity Investments | 165.18K | 141.01K | 100.74K | 11.00K | 48.73K | 46.34K |
| Stock-Based Compensation | 4.25M | 8.90M | 5.39M | 5.55M | 7.71M | 4.89M |
| Other Operating Activities | 5.15M | -4.97M | 3.99M | 5.65M | 3.10M | 793.69K |
| Change in Accounts Receivable | 107.13K | -1.49M | ||||
| Change in Inventory | -916.81K | -3.34M | ||||
| Change in Accounts Payable | -3.60M | 1.67M | 1.39M | 3.08M | 1.30M | -198.47K |
| Change in Other Net Operating Assets | -291.76K | 9.58M | -4.41M | 1.67M | -2.98M | -6.88M |
| Operating Cash Flow | -56.15M | -51.83M | -68.79M | -42.97M | -56.67M | -54.25M |
| Investment in Securities | -2.10M | |||||
| Investing Cash Flow | -2.10M | |||||
| Long-Term Debt Issued | 33.10M | 30.00M | 10.00M | 10.00M | ||
| Long-Term Debt Repaid | -36.14M | -4.27K | -10.23M | -12.32M | -3.69M | |
| Net Debt Issued (Repaid) | -2.33M | -3.04M | -4.27K | 19.77M | -2.32M | 6.31M |
| Issuance of Common Stock | 65.38M | 48.03M | 60.33M | 30.02M | 62.51M | 49.90M |
| Other Financing Activities | -2.46M | -823.89K | -600.00K | -8.03K | ||
| Financing Cash Flow | 60.60M | 44.98M | 60.33M | 48.97M | 59.59M | 56.19M |
| Net Cash Flow | 2.34M | -6.84M | -8.46M | 6.00M | 2.92M | 1.94M |
| Free Cash Flow | -56.15M | -51.83M | -68.79M | -42.97M | -56.67M | -54.25M |
| Free Cash Flow Margin | -3,666.65% | |||||
| Free Cash Flow Per Share | -0.69 | -1.49 | -3.71 | -3.44 | -5.34 | -7.11 |
| Levered Free Cash Flow | -37.36M | -27.15M | -44.30M | -24.26M | -32.53M | -35.62M |
| Unlevered Free Cash Flow | -37.19M | -26.97M | -42.33M | -22.68M | -31.60M | -35.03M |
| Cash Interest Paid | 475.00K | 1.16M | 1.56M | 46.24K | ||
| Change in Working Capital | -4.70M | 6.41M | -3.02M | 4.75M | -1.68M | -7.08M |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 114.23M | 47.08M | 126.32M | 57.51M | 275.90M | 380.49M |
| Enterprise Value | 121.41M | 72.88M | 127.02M | 58.55M | 260.39M | 372.48M |
| Last Close Price | 0.47 | 1.06 | 5.34 | 4.42 | 24.40 | 43.40 |
| PS Ratio | 33.31 | |||||
| PB Ratio | -1.46 | -1.73 | -3.98 | 31.58 | 82.58 | |
| P/TBV Ratio | 31.58 | 82.58 | ||||
| EV/Sales Ratio | 51.56 | |||||
| Debt / Equity Ratio | -1.77 | -0.94 | -0.41 | -2.46 | 1.25 | 2.58 |
| Net Debt / Equity Ratio | -0.69 | -0.69 | -0.20 | -0.84 | -0.74 | -0.56 |
| Net Debt / EBITDA Ratio | -0.13 | -0.33 | -0.21 | -0.23 | 0.10 | 0.05 |
| Net Debt / FCF Ratio | -0.13 | -0.43 | -0.21 | -0.28 | 0.11 | 0.05 |
| Asset Turnover | 0.06 | |||||
| Quick Ratio | 0.45 | 0.21 | 0.35 | 0.50 | 0.88 | 2.14 |
| Current Ratio | 0.81 | 0.38 | 0.64 | 0.66 | 1.40 | 3.19 |
| Return on Equity (ROE) | -989.99% | -1,430.33% | ||||
| Return on Assets (ROA) | -143.17% | -176.82% | -146.63% | -109.17% | -153.56% | -151.98% |
| Return on Capital Employed (ROCE) | 2,230.60% | 246.30% | 522.20% | 368.10% | -716.90% | -322.10% |
| Earnings Yield | -159.41% | -132.58% | -59.66% | -102.55% | -23.94% | -13.97% |
| FCF Yield | -49.16% | -110.08% | -54.46% | -74.72% | -20.54% | -14.26% |
| Buyback Yield / Dilution | -182.49% | -87.59% | -48.29% | -17.96% | -38.91% | -110.43% |